go back

Michigan rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $1,122,018 · 10th–90th $562,341–$1,778,2790%10%10th90th$1,122,018Professionalmedian $575,440 · 10th–90th $549,541–$724,4360%50%10th90th$575,440$100.0K$200.0K$500.0K$1.0M$2.0M$5.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$575,439.94 / $1,122,018.45 / $1,778,279.41
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $575,439.94 / $707,945.78
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$144,543.98 / $1,096,478.20 / $2,238,721.14
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$512,861.38 / $549,540.87 / $549,540.87
Health Alliance Plan
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$575,439.94 / $1,122,018.45 / $1,778,279.41
Health Alliance Plan
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $575,439.94 / $851,138.04
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$524,807.46 / $562,341.33 / $562,341.33
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $588,843.66 / $660,693.45